Enricoso, Bb Boy .

HRN: 21-26-28  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2022
AMPICILLIN 250MG (VIAL)
04/30/2022
05/07/2022
IV
50 Mg
Q12h
Neonatal Sepsis
Waiting Final Action 
04/30/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/30/2022
05/07/2022
IV
15 Mg
Q36h
Neonatal Sepsis
Waiting Final Action 
05/02/2022
CEFTRIAXONE 1G (VIAL)
05/02/2022
05/08/2022
IVT
50mg
Q24H
Sepsis Neonatorum
Waiting Final Action 
05/02/2022
CEFTRIAXONE 1G (VIAL)
05/02/2022
05/08/2022
IVT
50mg
Q24H
Neonatal Sepsis
Waiting Final Action 
05/06/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/06/2022
05/13/2022
IV
50mg
Q12
Neonatal Sepsis
05/17/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/17/2022
05/23/2022
IV
10mg
Q8
Necrotizing Enterocolitis
Waiting Final Action 
06/16/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
06/16/2022
06/22/2022
IV
5mg
Q24
Neonatal Sepsis
Waiting Final Action 
06/16/2022
CEFTAZIDIME 1GM (VIAL)
06/16/2022
06/22/2022
IV
50mg
Q8
Neonatal Sepsis
Waiting Final Action 
06/30/2022
CIPROFLOXACIN 500MG (TAB)
06/30/2022
07/07/2022
PO
200mg/pptab
Q12h
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: